MedTrace Logo

GSK372475 Bioequivalence Study

NCT00488098 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2012-06-04

No results posted yet for this study

Summary

The study is to show the new salt formulation of GSK372475 is equivalent to the old salt formulation of GSK372475.

Conditions

  • Healthy Subjects
  • Depressive Disorder

Interventions

DRUG

GSK372475

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00488098 on ClinicalTrials.gov